MAP2K7 and neoplasm: ROS1 alterations, particularly gene fusions, are pivotal in oncogenesis by activating RAS-RAF-MEK-ERK, PI3K-AKT-mTOR, and JAK-STAT3 signaling pathways, driving tumor cell proliferation and survival [68].